Danesh Kimia Pharmed

Established in 2011 by a group of industrial and academic researchers, Danesh Kimia Pharmed Co. was founded to focus on the development of new pharmaceutical molecules and their respective ready-to-use dosage forms. The company has positioned itself as a leading producer of generic pharmaceuticals for novel compounds and ready-to-use formulations through its research and production units. Notably, it has established a production line for anticancer active ingredients at Baran Chemical and Pharmaceutical Co., as well as low-quantity high-value molecules like Fingolimod, Nitisinone, Bosentan, and more.